Page 9 of 9
« First‹ Prev789

Marvel SW, House JS, Wheeler MW, Song K, Zhou Y-H, Wright FA, Chiu WA, Rusyn I, et al. 2021. The COVID-19 Pandemic Vulnerability Index (PVI) Dashboard: Monitoring county-level vulnerability using visualization, statistical modeling, and machine learning. Environ Health Perspect 129(1):017701; doi: 10.1289/EHP8690. PMID: 33400596.

View Abstract

Hathway J, Miller-Wilson L, Yao W, Jensen I, Weinstein M, Parks P. 2021. The health economic impact of varying levels of adherence to colorectal screening on providers and payers. J Med Econ 24(1):69–78; doi: 10.1080/13696998.2020.1858607. PMID: 33970747.

View Abstract

Brozek JL, Canelo-Aybar C, Akl EA, Bowen JM, Bucher J, Chiu WA, Cronin M, Djulbegovic B,…, Patlewicz G, et al. 2021. GRADE Guidelines 30: The GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making. J Clin Epidemiol 129(Jan):138-150; doi: 101016/j.jclinepi.2020.09.018. PMID: 32980429.

View Abstract

Rovida C, Escher SE, Herzler M, Bennekou SH, Kamp H, Kroese DE, Maslankiewicz L, Moné MJ, Patlewicz G, et al. 2021. NAM-supported read-across: From case studies to regulatory guidance in safety assessment. ALTEX 38(1):140-150; doi: 10.14573/altex.2010062. PMID: 33452529.

View Abstract

Frankenfeld CL, Hakes JK, Leslie TF. 2021. All-cause mortality and residential racial and ethnic segregation and composition as experienced differently by individual-level race, ethnicity, and gender: Mortality disparities in American communities data. Ann Epidemiol 65(Jan):38-45; doi: 10.1016/j.annepidem.2021.10.008. PMID: 34757014.

View Abstract

Wheeler MW, Westerhout J, Baumert JL, Remington BC. 2021. Bayesian stacked parametric survival with frailty components and interval‐censored failure times: An application to food allergy risk. Risk Anal 41(1):56-66; doi: 10.1111/risa.13585. PMID: 33063372.

View Abstract

Chappell GA, Heintz MM, Haws LC. 2021. Transcriptomic analyses of livers from mice exposed to 1,4-dioxane for up to 90 days to assess potential mode(s) of action underlying liver tumor development. Curr Res Toxicol 2:30–41; doi: 10.1016/j.crtox.2021.01.003. PMID: 34345848.

View Abstract
Page 9 of 9
« First‹ Prev789